Market Overview

Benzinga's Top Downgrades

Related FINL
Goldman Sachs Upgrade Not Helping Finish Line
Goldman Upgrades Finish Line, Removes From Americas Sell List
Related ELN
Perrigo, Elan Receive Irish High Court Approval for Perrigo's Proposed Acquisition of Elan
Perrigo Shareholders Approve Acquisition Of Elan

Sterne Agee downgraded Finish Line Inc (NASDAQ: FINL) from “buy” to “neutral.” FINL's shares closed at $21.13 yesterday. Finish Line's trailing-twelve-month operating margin is 9.97%.

Analysts at UBS downgraded Elan Corporation plc (NYSE: ELN) from “buy” to “neutral.” ELN's shares closed at $14.50 yesterday. Elan's PEG ratio is -19.57.

RW Baird downgraded Amylin Pharmaceuticals Inc (NASDAQ: AMLN) from “outperform” to “neutral.” AMLN's shares closed at $27.44 yesterday. Amylin Pharmaceuticals' trailing-twelve-month ROE is -348.55%.

William Blair downgraded Booz Allen Hamilton Inc (NYSE: BAH) from “outperform” to “market perform.” BAH's shares closed at $16.86 yesterday. Booz Allen Hamilton's trailing-twelve-month profit margin is 3.57%.

Latest Ratings for FINL

Oct 2015JP MorganMaintainsNeutral
Oct 2015Goldman SachsUpgradesSellNeutral
Sep 2015BarclaysMaintainsEqual-weight

View More Analyst Ratings for FINL
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings


Related Articles (AMLN + BAH)

View Comments and Join the Discussion!

Get Benzinga's Newsletters